Ling Yang

Ling is a senior epidemiologist at The Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) and the Medical Research Council Population Health Research Unit at the University of Oxford (MRC PHRU), and leads the long-term follow-up working group, women health and infection and cancer research groups in the China Kadoorie Biobank study (CKB).

Her main research focus are on women’s reproductive health, chronic infection and environmental causes of chronic diseases (especially cancer) based on large scale cohort studies, and evidence-based medicine using large national disease surveillance and risk factors survey data to provide strategies for chronic disease prevention and control in developing countries.

Before moving to the University of Oxford in 2007, Ling worked at the Chinese Academy of Medical Science (CAMS) and Ministry of Health in Beijing (China), WHO International Agency for Research on Cancer in Lyon (IARC/WHO, France) and Karolinska Institutet in Stockholm (Sweden).

Ling qualified in Medicine at South-Eastern University (China) in 1995 then gained her MSc in Bio-statistics in 1998 there, and her PhD in Epidemiology at the University of Tampere (Finland) in 2005.